Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Postoperative Analgesia in Gynecologic Laparoscopy
NCT06288841Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Nov 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine in postoperative pain (4 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Numeric Rating Scale Pain Score at 72 hours. Started Nov 2023; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06288841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06288841.